Caption
Researcher in a laboratory
Funding boost for promising treatment
Date
Research news
Date
A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Date
New research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
Date
In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson’s diagnosis.
Date
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Date
Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Date
Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
Date
Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.
Date
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
Date
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Date
Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.